pharmaphorum

DECEMBER 23, 2022

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance.

Marketing 95

Marketing Sales Medical Patients 95

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.

Patients 59

Patients Pharma Education Media 59

Pharmaceutical Technology

SEPTEMBER 8, 2022

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time.

Specialization 45

Specialization Leads Pharma Side effects 45

Clarivate

NOVEMBER 23, 2021

Learnings from bringing clinical trial management in-house, and how to modernize your approach to patient-first trials with advanced data science, real-world data and other patient intelligence. Clearly, making sure that we’ve got the right patients and principal investigators is still a challenge.

Patients 52

Patients Recruitment Management Healthcare 52

pharmaphorum

JULY 27, 2022

Demerging Haleon has allowed GSK to focus on higher-margin prescription medicines and vaccines, as well as provide cash for investment in its biopharma pipeline. GSK’s HIV business, run through joint venture company ViiV Healthcare, also had a good quarter with sales up 14% to £1.4 Total revenues came in at £6.9

Sales 52

Sales Biopharma Prescription Medicine 52

MedCity News

JUNE 16, 2023

Investors in 2022 appeared confident that the continued transformation of drug research and development protocols and the overall life sciences industry will not only include digital health solutions, but will even depend on them for data collection, analysis, patient engagement, and even their therapeutic properties.

Pharma 101

Pharma Food and Drug Administration Recruitment Pharmacology 101

Pharmaceutical Technology

NOVEMBER 4, 2022

Any reduced availability of medicines has a significant impact on patient care. As visibility diminishes, mismanagement of the supply chain can not only lead to revenue and reputational damage for manufacturers but more importantly, loss of life for patients. The CMO solution.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

Eversana Intouch

FEBRUARY 23, 2023

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Biopharma valuations are down, especially for public and earlier-stage companies. Implications of economic volatility abound: Patients: Market access gaps.

Marketing 52

Marketing Pharma Patients Insurance 52

Eversana Intouch

FEBRUARY 23, 2023

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Biopharma valuations are down, especially for public and earlier-stage companies. Implications of economic volatility abound: Patients: Market access gaps.

Marketing 52

Marketing Pharma Patients Insurance 52

Clarivate

JULY 5, 2023

biologics market and reduce prescription drug costs. This strategy is reacting to the cost challenges patients face and is an “affordable solution for patients who are uninsured, underinsured, or recently separated from Medicaid coverage,” said Coherus chief business officer Chris Slavinsky in a statement.

Marketing 97

Marketing Physicians Manufacturing Competition 97

PM360

JULY 21, 2022

Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks. 2 The percentage of healthcare providers willing to see pharmaceutical company reps in person had declined from 67% in 2018 to 54% in 2019. Fierce Healthcare.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. Accelerated approvals are really important to society and patient populations, and industry,” Califf told the JP Morgan Conference. “[But]

FDA 52

FDA Prescription Medicine Biopharma 52

Clarivate

MAY 11, 2023

Mainland China has streamlined regulatory protocols for testing and approving prescription drugs in recent years, making dozens of urgently needed treatments, from domestic and international manufacturers alike, available to patients in the process.

Marketing 52

Marketing Patients Management Insurance 52

Clarivate

OCTOBER 30, 2022

Half of the psychiatrists surveyed reported having prescribed or recommended DTx to patients within the three studied indications, while the remainder indicated they expect or are open to prescribing them. Nearly two-thirds of MCOs developed a comprehensive coverage policy for DTx, while the rest are working on or intend to develop one.

Insurance 52

Insurance FDA Prescription Marketing 52

MedCity News

JUNE 12, 2023

One of the fastest-growing frontiers of healthcare is Digital Therapeutics (DTx), which utilizes clinically tested software to prevent, treat, and manage a growing range of medical conditions. The goal was simple: provide access and focused support to patients remotely while simultaneously relieving overtaxed healthcare facilities.

Food and Drug Administration 86

Food and Drug Administration Prescription Government FDA 86

Clarivate

FEBRUARY 28, 2023

LHON mutation rate variability affects therapeutic efficacy Most LHON patients carry one of three pathogenic mitochondrial DNA mutations (11778G>A [ND4], 14484T>C [ND6] and 3460G>A [ND1]) known as primary LHON mutations. We identified patients with an LHON diagnosis using ICD-10 and ICD-9 codes H47.2 The Clarivate U.S.

Prescription 98

Prescription Patients Pharmacology Healthcare 98

Clarify Health

MAY 19, 2020

The time-consuming and resource-intensive path from the lab bench to the patient bedside starts with drug discovery, progresses to pre-clinical and clinical research, and then enters regulatory review. Any misstep in terms of pricing, reimbursement, or marketing could mean delays in providing therapies to the patients who need them most.

Biopharma 52

Biopharma Physicians Marketing Prescription 52

Clarivate

AUGUST 8, 2023

The biopharma industry is sweating the long-term implications and warning that it could mean less lifesaving drugs make it to patients going forward. The law was top-of-mind at this summer’s ASCO and BIO meetings, tentpole events in the biopharma conference calendar. The vise on revenues also makes differentiation essential.

Biopharma 52

Biopharma Pharma Prescription Manufacturing 52

Clarivate

MARCH 17, 2022

Lack of information based on clinical data can mean providers and patients decide against treating underlying conditions, “which in some cases may result in more harm” to the parent and the fetus than if they had received treatment.

Food and Drug Administration 10

Food and Drug Administration Safety FDA Ethics 10